Consumer Marketing briefs

Share this article:
New York-Presbyterian Hospital launched an ad campaign, dubbed Amazing Things Are Happening Here. Executed by Munn Rabôt, the campaign features five new TV spots, outdoor ads, Facebook and Twitter presence and a dedicated microsite with in-depth patient interviews and physician information, as well as brand sponsorships of the Yankees and the Giants including stadium signage and program advertising.

A Partners + Simons survey of attitudes towards advertising found that only 23% of print and radio ads were seen by consumers as containing a credible central message. TV spots didn't fare much better, with 30% deemed credible. “The truth aside, audiences are not generally willing to accept what these advertisers have to say about themselves,” said CEO Tom Simons.

An AstraZeneca survey pushing back at therapeutic substitution of generics for branded drugs found that 84% of American patients want their physician to be the leading decision maker in what prescription meds they take, and that 87% want to be told at the pharmacy if they are not getting their originally prescribed medication. AstraZeneca, of course, makes Crestor, and rival Lipitor just went generic.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?